A practical guidance on the use of intravenous insulin infusion for management of inpatient hyperglycemia : Intravenous Insulin Infusion for Management of Inpatient Hyperglycemia
Copyright © 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved..
BACKGROUND: We aim to provide a practical guidance on the use of intravenous insulin infusion for managing inpatient hyperglycemia.
METHODS AND RESULTS: This document was formulated based on the review of available literature and personal experience of authors. We have used various case scenarios to illustrate variables which should be taken into account when deciding adjustments in infusion rate, including but not restricted to ambient blood glucose level and magnitude of blood glucose change in the previous hour.
CONCLUSION: The guidance can be generalized to any situation where dedicated protocols are lacking, trained manpower is not available and resource constraints are present.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Diabetes & metabolic syndrome - 15(2021), 5 vom: 07. Sept., Seite 102244 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Goyal, Alpesh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood Glucose |
|---|
| Anmerkungen: |
Date Completed 04.10.2021 Date Revised 04.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.dsx.2021.102244 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329688456 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329688456 | ||
| 003 | DE-627 | ||
| 005 | 20231225205645.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.dsx.2021.102244 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1098.xml |
| 035 | |a (DE-627)NLM329688456 | ||
| 035 | |a (NLM)34425556 | ||
| 035 | |a (PII)S1871-4021(21)00264-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Goyal, Alpesh |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A practical guidance on the use of intravenous insulin infusion for management of inpatient hyperglycemia |b Intravenous Insulin Infusion for Management of Inpatient Hyperglycemia |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.10.2021 | ||
| 500 | |a Date Revised 04.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved. | ||
| 520 | |a BACKGROUND: We aim to provide a practical guidance on the use of intravenous insulin infusion for managing inpatient hyperglycemia | ||
| 520 | |a METHODS AND RESULTS: This document was formulated based on the review of available literature and personal experience of authors. We have used various case scenarios to illustrate variables which should be taken into account when deciding adjustments in infusion rate, including but not restricted to ambient blood glucose level and magnitude of blood glucose change in the previous hour | ||
| 520 | |a CONCLUSION: The guidance can be generalized to any situation where dedicated protocols are lacking, trained manpower is not available and resource constraints are present | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Continuous glucose monitoring system | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Inpatient hyperglycemia | |
| 650 | 4 | |a Insulin infusion | |
| 650 | 4 | |a Steroid induced hyperglycemia | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 650 | 7 | |a Insulin |2 NLM | |
| 700 | 1 | |a Mathew, Uthara Elsa |e verfasserin |4 aut | |
| 700 | 1 | |a Golla, Kiran Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Mannar, Velmurugan |e verfasserin |4 aut | |
| 700 | 1 | |a Kubihal, Suraj |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Yashdeep |e verfasserin |4 aut | |
| 700 | 1 | |a Tandon, Nikhil |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes & metabolic syndrome |d 2007 |g 15(2021), 5 vom: 07. Sept., Seite 102244 |w (DE-627)NLM189445564 |x 1878-0334 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2021 |g number:5 |g day:07 |g month:09 |g pages:102244 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.dsx.2021.102244 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2021 |e 5 |b 07 |c 09 |h 102244 | ||